Justin Stebbing and Andrea Bullock
Mar 18, 2025, 11:48
Justin Stebbing: CD47 as a potential predictive biomarker in colorectal cancer
Justin Stebbing, Professor of Cancer Medicine and Oncology at Imperial College, shared an article on LinkedIn:
“I wrote this editorial with the fantastic Andrea Bullock from Harvard on CD47, a fascinating immunotherapy target but very much work in progress.”
CD47 as a potential predictive biomarker in colorectal cancer.
Authors: Justin Stebbing and Andrea Bullock
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 2, 2025, 15:24
May 2, 2025, 14:52
May 2, 2025, 14:44
May 2, 2025, 14:40
May 2, 2025, 14:32